Picture of Ryvu Therapeutics SA logo

RVU Ryvu Therapeutics SA News Story

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Ryvu Therapeutics Q2 Net Loss Narrows To 28.5 Mln Zlotys

Sept 13 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * Q2 NET LOSS 28.5 MILLION ZLOTYS VERSUS LOSS OF 36.9
MILLION
ZLOTYS YEAR AGO
    * Q2 OPERATING REVENUE 15.0 MILLION ZLOTYS VERSUS 7.3
MILLION
ZLOTYS YEAR AGO
    * Q2 OPERATING LOSS 31.6 MILLION ZLOTYS VERSUS LOSS OF 38.1
MILLION ZLOTYS YEAR AGO

Source text for Eikon:  ID:nEM3mz8vJa 
Further company coverage:  RVU.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))

Recent news on Ryvu Therapeutics SA

See all news